Studi ini bertujuan menganalisis dampak COVID-19 terhadap perdagangan (ekspor dan impor) pada industri farmasi di negara anggota ASEAN. Dengan menggunakan metode Pseudo Poisson Maximum Likelihood (PPML) serta data jumlah kasus kumulatif COVID-19 dan data nilai ekspor dan impor industri farmasi selama periode Januari 2019 sampai Desember 2020, hasil estimasi menunjukkan bahwa jumlah kasus terinfeksi pada negara anggota ASEAN tidak berpengaruh terhadap nilai ekspor produk farmasi negara anggota ASEAN. Adapun di sisi impor, jumlah kasus terinfeksi COVID19 kumulatif pada negara ASEAN berdampak secara positif signifikan terhadap nilai impor produk farmasi negara anggota ASEAN.

---

This study aims to analysis the impact of COVID-19 on trade (exports and imports) in the pharmaceutical industry in ASEAN member countries. By using the Pseudo Poisson Maximum Likelihood (PPML) method as well as data on the cumulative number of COVID-19 cases and data on exports and imports of the pharmaceutical industry during the period January 2019 to December 2020, the estimation results show that the number of infected cases in ASEAN member countries has no effect on export value. pharmaceutical products of ASEAN member countries. On the import side, the number of cumulative COVID-19 infected cases in ASEAN countries has a significant positive impact on the import value of pharmaceutical products from ASEAN member countries.